United States · FDA National Drug Code directory
DESVENLAFAXINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8760_337771e1-3a8c-47e1-9c09-4df4abfaef3b
- Product NDC
- 68788-8760
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- DESVENLAFAXINE
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241111
- Source listing expiry
- 20271231
Source-listed ingredients
- DESVENLAFAXINE SUCCINATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-1) · 68788-8760-1
- 30 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-3) · 68788-8760-3
- 60 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-6) · 68788-8760-6
- 90 TABLET, EXTENDED RELEASE in 1 PACKAGE (68788-8760-9) · 68788-8760-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →